These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16781213)

  • 1. Cardiovascular disease in HIV infection.
    Sudano I; Spieker LE; Noll G; Corti R; Weber R; Lüscher TF
    Am Heart J; 2006 Jun; 151(6):1147-55. PubMed ID: 16781213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of the involvement of the cardiovascular system in HIV infection.
    Barbarinia G; Barbaro G
    AIDS; 2003 Apr; 17 Suppl 1():S46-50. PubMed ID: 12870530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
    Calza L; Manfredi R; Pocaterra D; Chiodo F
    J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy with heart.
    Randell P; Moyle G
    Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and the cardiovascular system.
    Barbaro G; Klatt EC
    AIDS Rev; 2002; 4(2):93-103. PubMed ID: 12152522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical cardiac manifestations of HIV infection: a review of current literature.
    Chu WW; Sosman JM; Stein JH
    WMJ; 2002; 101(7):40-5, 39. PubMed ID: 12426919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk.
    Barbaro G
    Am J Ther; 2006; 13(3):248-60. PubMed ID: 16772767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac manifestations in HIV-infected individual].
    Neumann T; Ross B; Hengge UR; Gerken G; Erbel R
    Med Klin (Munich); 2002 Nov; 97(11):659-65. PubMed ID: 12434274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular manifestations in human immunodeficiency virus-infected patients.
    Khunnawat C; Mukerji S; Havlichek D; Touma R; Abela GS
    Am J Cardiol; 2008 Sep; 102(5):635-42. PubMed ID: 18721528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing HIV. Part 5: Treating secondary outcomes. 5.9 HIV-related cardiovascular disease.
    Feneley MP
    Med J Aust; 1996 Apr; 164(8):482. PubMed ID: 8614340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.